Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4291999
Max Phase: Preclinical
Molecular Formula: C41H45ClF3N3O5
Molecular Weight: 752.27
Molecule Type: Small molecule
Associated Items:
ID: ALA4291999
Max Phase: Preclinical
Molecular Formula: C41H45ClF3N3O5
Molecular Weight: 752.27
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1cc(Cl)cc(C(F)(F)F)c1)C(C)C
Standard InChI: InChI=1S/C41H45ClF3N3O5/c1-25(2)37(48-39(51)30-20-31(41(43,44)45)22-32(42)21-30)40(52)46-33(18-28-14-7-5-8-15-28)23-35(49)34(19-29-16-9-6-10-17-29)47-36(50)24-53-38-26(3)12-11-13-27(38)4/h5-17,20-22,25,33-35,37,49H,18-19,23-24H2,1-4H3,(H,46,52)(H,47,50)(H,48,51)/t33-,34-,35-,37-/m0/s1
Standard InChI Key: YHJALBCRAMLRSM-SZHYKVQFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 752.27 | Molecular Weight (Monoisotopic): 751.3000 | AlogP: 7.02 | #Rotatable Bonds: 16 |
Polar Surface Area: 116.76 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.41 | CX Basic pKa: | CX LogP: 8.02 | CX LogD: 8.02 |
Aromatic Rings: 4 | Heavy Atoms: 53 | QED Weighted: 0.10 | Np Likeness Score: -0.49 |
1. Matralis AN, Xanthopoulos D, Huot G, Lopes-Paciencia S, Cole C, de Vries H, Ferbeyre G, Tsantrizos YS.. (2018) Molecular tools that block maturation of the nuclear lamin A and decelerate cancer cell migration., 26 (20): [PMID:30309670] [10.1016/j.bmc.2018.10.001] |
Source(1):